Atlas Trials

Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)

Clinical trial NCT07025005 · RECRUITING

Trial details

NCT number
NCT07025005
Sponsor
Tanta University
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Peripheral NeuropathyMultiple Myeloma, Neoplasms
Start date
2025-08-30
Primary completion
2026-06-30
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.